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Materials and Methods  
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage 
through an activated alumina column under argon.1 Reaction progress was monitored by thin-
layer chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck 
silica gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence 
quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic Silica gel 
(particle size 40–63 nm) was used for flash chromatography.  1H NMR spectra were recorded on 
Varian Inova 500 MHz and Bruker 400 MHz spectrometers and are reported relative to residual 
CHCl3 (δ 7.26 ppm).  13C NMR spectra were recorded on a Varian Inova 500 MHz spectrometer 
(125 MHz) and Bruker 400 MHz spectrometers (100 MHz) and are reported relative to CHCl3 
(δ 77.16 ppm). Data for 1H NMR are reported as follows: chemical shift (δ ppm) (multiplicity, 
coupling constant (Hz), integration).  Multiplicities are reported as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, br 
d = broad doublet.  Data for 13C NMR are reported in terms of chemical shifts (δ ppm).  IR 
spectra were obtained by use of a Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 
FTIR spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm–1).  Optical rotations were measured with a Jasco P-2000 polarimeter operating 
on the sodium D-line (589 nm), using a 100 mm path-length cell.  Analytical SFC was performed 
with a Mettler SFC supercritical CO2 analytical chromatography system utilizing Chiralpak (AD-
H, AS-H or IC) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from 
Daicel Chemical Industries, Ltd. High resolution mass spectra (HRMS) were obtained from 
Agilent 6200 Series TOF with an Agilent G1978A Multimode source in electrospray ionization 
(ESI+), atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: 
ESI-APCI+).  Absolute configuration of 2b was determined by comparison of the optical 
rotation to literature reported value,2 and all other products are assigned by analogy. 
Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa Aesar and 
used as received unless otherwise stated. Ligands L1,3 L2,4 and L45 and trisubstituted ketones6 
were prepared by known methods. 
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List of Abbreviations: 
ee – enantiomeric excess, SFC – supercritical fluid chromatography, TLC – thin-layer 
chromatography, IPA – isopropanol 
 
General Procedure for Pd-Catalyzed Allylic Alkylation Reactions 
 
In a nitrogen-filled glovebox, a solution of Pd2(dba)3 (1.8 mg/mL) and L2 (2.8 mg/mL) in 
toluene was stirred for 30 minutes at 25 °C, then 0.5 mL of the resulting catalyst solution was 
added to a one dram vial containing allyl enol carbonate substrate (0.2 mmol) dissolved in 
hexanes (1.5 mL).  The vial was sealed with a Teflon-lined cap, removed from the glovebox, and 
stirred at 25 °C for 12 h.  The crude reaction mixture was concentrated then purified by silica gel 
flash chromatography to provide the desired alkylation product. 
 
  
 (R)-2-ethyl-1,2-diphenylpent-4-en-1-one (2a) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (51.1 mg, 
97% yield); 91% ee, [α]D25 –107.5 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.44–7.33 (m, 
5H), 7.31–7.25 (m, 3H), 7.24–7.17 (m, 2H), 5.38 (dddd, J = 16.8, 10.3, 8.2, 6.5 Hz, 1H), 5.03–
4.85 (m, 2H), 2.91–2.72 (m, 2H), 2.16 (qd, J = 7.4, 3.3 Hz, 2H), 0.69 (t, J = 7.5 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 203.3, 142.7, 137.3, 133.6, 131.8, 129.5, 129.0, 128.1, 127.1, 127.0, 
118.3, 58.2, 39.3, 26.9, 8.0; IR (Neat Film, NaCl) 3065, 2973, 2940, 2879, 1675, 1597, 1578, 
1496, 1446, 1227, 1182, 1142, 1004, 917, 839, 764, 714, 702, 654 cm–1; HRMS (MM:ESI-
APCI+) m/z calc’d for C19H21O [M+H]+: 265.1587, found 265.1577; SFC Conditions: 2% IPA, 
2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 5.33, major = 5.76. 
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(R)-2-methyl-1,2-diphenylpent-4-en-1-one (2b) 
Purified by column chromatography (3% Et2O in hexanes) to provide a colorless oil (48.3 mg, 
96% yield); 67% ee, [a]D25 –111.9 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ  7.48–7.42 (m, 
2H), 7.40–7.33 (m, 3H), 7.33–7.27 (m, 3H), 7.24–7.18 (m, 2H), 5.51 (dddd, J = 17.0, 10.2, 7.7, 
6.9 Hz, 1H), 5.08–4.87 (m, 2H), 2.89–2.71 (m, 2H), 1.58 (s, 3H); 13C NMR (100 MHz, CDCl3) δ  
203.3, 143.6, 136.9, 134.1, 131.8, 129.7, 129.1, 128.1, 127.1, 126.4, 118.5, 54.4, 44.8, 23.8; IR 
(Neat Film, NaCl) 3065, 3024, 2977, 2935, 1677, 1638, 1597, 1578, 1496, 1446, 1376, 1240, 
1182, 1139, 1078, 1028, 1001, 970, 917, 762, 716, 701 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C18H19O [M+H]+: 251.1430, found 251.1418; SFC Conditions: 2% IPA, 2.5 mL/min, 
Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 7.02, major = 7.44. 
O
Me
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(S)-2-benzyl-1,2-diphenylpent-4-en-1-one (2c) 
Purified by column chromatography (3% Et2O in hexanes) to provide a white solid (64.9 mg, 
99% yield); 76% ee, [α]D25 +102.5 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.48–7.40 (m, 
2H), 7.37–7.23 (m, 4H), 7.23–7.13 (m, 2H), 7.12–6.97 (m, 5H), 6.58–6.49 (m, 2H), 5.64 (ddt, J 
= 17.2, 10.2, 7.1 Hz, 1H), 5.07–4.97 (m, 1H), 4.84 (dd, J = 17.0, 1.8 Hz, 1H), 3.41–3.26 (m, 2H), 
2.90–2.67 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 202.2, 142.2, 137.2, 137.1, 133.2, 131.9, 
130.9, 129.9, 129.0, 128.1, 127.6, 127.4, 127.3, 126.3, 119.4, 59.0, 42.1, 37.9; IR (Neat Film, 
NaCl) 3062, 1674, 1597, 1579, 1496, 1446, 1269, 1216, 1180, 1078, 1026, 912, 768, 722, 701 
cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C24H23O [M+H]+: 327.1743, found 327.1748; 
SFC Conditions: 10% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): minor = 
5.47, major = 5.97. 
O
Bn
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(R)-2-allyl-1,2-diphenylhexan-1-one (2d) 
Purified by column chromatography (3% Et2O in hexanes) to provide a colorless oil (58.2 mg, 
99% yield); 87% ee, [α]D25 –112.6 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.41–7.28 (m, 
5H), 7.28–7.20 (m, 3H), 7.16 (dd, J = 8.2, 7.0 Hz, 2H), 5.35 (dddd, J = 16.8, 10.3, 7.9, 6.7 Hz, 
1H), 4.98–4.80 (m, 2H), 2.92–2.67 (m, 2H), 2.06 (dt, J = 9.9, 4.9 Hz, 2H), 1.23–0.99 (m, 3H), 
0.96–0.78 (m, 1H), 0.71 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.3, 142.8, 137.3, 
133.7, 131.7, 129.5, 129.0, 128.0, 127.1, 126.9, 118.3, 57.8, 40.0, 33.8, 25.6, 23.2, 13.9; IR (Neat 
Film, NaCl) 3064, 2956, 2871, 2861, 1676, 1639, 1597, 1578, 1496, 1466, 1446, 1254, 1240, 
1212, 1181, 1144, 1001, 918, 764, 720, 701 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C21H25O [M+H]+: 293.1900, found 293.1898; SFC Conditions: 5% IPA, 2.5 mL/min, Chiralpak 
AD-H column, λ = 210 nm, tR (min): minor = 4.44, major = 5.27. 
O
Bu
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(S)-2-(cyclopropylmethyl)-1,2-diphenylpent-4-en-1-one (2e) 
Purified by column chromatography (3% Et2O in hexanes) to provide a colorless oil (56.5 mg, 
97% yield); 91% ee, [α]D25 –57.6 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.48–7.43 (m, 
2H), 7.37–7.33 (m, 3H), 7.30–7.25 (m, 3H), 7.22–7.17 (m, 2H), 5.42 (ddt, J = 17.3, 10.2, 7.2 Hz, 
1H), 5.04–4.80 (m, 2H), 3.04 (dt, J = 7.2, 1.3 Hz, 2H), 2.16 (dd, J = 14.1, 6.1 Hz, 1H), 2.03 (dd, 
J = 14.1, 7.0 Hz, 1H), 0.49–0.38 (m, 1H), 0.36–0.22 (m, 2H), -0.09 (dtd, J = 8.4, 5.0, 3.7 Hz, 
1H), –0.18 – -0.27 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 202.9, 143.1, 137.1, 133.8, 131.8, 
129.8, 129.0, 128.1, 127.1, 126.9, 118.5, 58.8, 40.1, 39.3, 5.9, 4.9, 4.5; IR (Neat Film, NaCl) 
3075, 3003, 2936, 1676, 1639, 1597, 1579, 1496, 1446, 1273, 1221, 1181, 1151, 1019, 919, 762, 
719, 701 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H23O [M+H]+: 291.1743, found 
291.1743; SFC Conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR 
(min): minor = 6.27, major = 6.97. 
O
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(S)-1,2-diphenyl-2-(2,2,2-trifluoroethyl)pent-4-en-1-one (2f) 
Purified by preparative TLC (10% Et2O in hexanes) to provide a colorless oil (57.1 mg, 90% 
yield); 86% ee, [a]D25 +78.0 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.49–7.31 (m, 8H), 
7.24–7.18 (m, 2H), 5.45 (ddt, J = 17.3, 10.2, 7.3Hz, 1H), 5.08 (ddt, J = 10.2, 1.9, 1.0 Hz, 1H), 
4.96 (dq, J = 17.0, 1.5 Hz, 1H), 3.27–3.16 (m, 1H), 3.15 – 2.88 (m, 3H); 13C NMR (100 MHz, 
CDCl3) δ  200.4, 139.8, 136.4, 132.1, 131.8, 129.7, 129.4, 128.3, 128.0, 126.8 (q, J = 272.9 Hz), 
126.7, 120.6, 55.5 (d, J = 1.5 Hz), 39.1 (q, J = 26.7 Hz), 38.5 (d, J = 1.8 Hz); 19F NMR (282 
MHz, CDCl3) δ –58.4 (t, J = 11.1 Hz); IR (Neat Film, NaCl) 3067, 3027, 2985, 1678, 1642, 
1598, 1579, 1498, 1371, 1272, 1260, 1219, 1202, 1184, 1142, 1118, 1087, 1045, 1025, 982, 926, 
765, 727, 701 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H18F3O [M+H]+: 319.1304, 
found 319.1293; SFC Conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR 
(min): minor = 1.73, major = 2.17. 
O CF3
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(R)-2-ethyl-2-phenyl-1-(p-tolyl)pent-4-en-1-one (2g) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (52.1 mg, 
94% yield); 90% ee, [α]D25 –99.1 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.39–7.31 (m, 
4H), 7.31–7.21 (m, 3H), 7.04–6.97 (m, 2H), 5.38 (dddd, J = 16.7, 10.2, 8.3, 6.4 Hz, 1H), 4.99–
4.88 (m, 2H), 2.87 (ddt, J = 14.2, 8.3, 1.0 Hz, 1H), 2.78 (ddt, J = 14.2, 6.3, 1.4 Hz, 1H), 2.28 (s, 
3H), 2.20–2.11 (m, 2H), 0.69 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 202.7, 143.1, 
142.4, 134.4, 133.7, 129.7, 128.9, 128.8, 127.0, 127.0, 118.2, 58.1, 39.5, 27.0, 21.6, 8.0; IR (Neat 
Film, NaCl) 3063, 3026, 2973, 2879, 1673, 1640, 1606, 1496, 1446, 1230, 1182, 1001, 916, 824, 
774, 740, 704 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H23O [M+H]+: 279.1743, found 
279.1754; SFC Conditions(for cross-metathesis product, see pg S33): 5% IPA, 2.5 mL/min, 
Chiralcel OB-H column, λ = 210 nm, tR (min): minor = 4.14, major = 4.95. 
 
O
Et
Me
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ethyl (R)-4-(2-ethyl-2-phenylpent-4-enoyl)benzoate (2h) 
Purified by column chromatography (5% Et2O in hexanes) to provide a white solid (66.4 mg, 
99% yield); 90% ee, [α]D25 –79.7 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.90–7.84 (m, 
2H), 7.45–7.34 (m, 4H), 7.33–7.24 (m, 3H), 5.44–5.30 (m, 1H), 5.07–4.83 (m, 2H), 4.33 (q, J = 
7.1 Hz, 2H), 2.83 (dt, J = 7.6, 1.2 Hz, 2H), 2.14 (qq, J = 14.4, 7.3, 6.9 Hz, 2H), 1.34 (t, J = 7.1 
Hz, 3H), 0.69 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.0, 165.9, 142.1, 140.9, 
133.2, 132.9, 129.3, 129.3, 129.1, 127.4, 127.0, 118.5, 61.4, 58.4, 39.0, 26.7, 14.4, 7.9; IR (Neat 
Film, NaCl) 3076, 2977, 2940, 2879, 1722, 1581, 1649, 1599, 1580, 1570, 1495, 1462, 1446, 
1404, 1367, 1312, 1276, 1225, 1180, 1107, 1017, 1001, 918, 833, 788, 767, 727, 703 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C22H25O3 [M+H]+: 337.1798, found 337.1786; SFC 
Conditions(for cross-metathesis product, see pg S34): 7% IPA, 2.5 mL/min, Chiralcel OD-H 
column, λ = 210 nm, tR (min): minor = 9.38, major = 10.31. 
 
 
 
(R)-2-ethyl-1-(4-methoxyphenyl)-2-phenylpent-4-en-1-one (2i) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (58.4 mg, 
99% yield); 91% ee, [α]D25  –91.9 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.51–7.45 (m, 
2H), 7.38–7.31 (m, 2H), 7.26 (tt, J = 6.5, 1.1 Hz, 4H), 6.69 (d, J = 9.0 Hz, 1H), 5.38 (dddd, J = 
16.8, 10.3, 8.3, 6.3 Hz, 1H), 5.03–4.85 (m, 2H), 3.76 (s, 3H), 2.87 (ddt, J = 14.2, 8.3, 1.0 Hz, 
1H), 2.77 (ddt, J = 14.2, 6.4, 1.4 Hz, 1H), 2.19–2.12 (m, 2H), 0.69 (t, J = 7.4 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 201.5, 162.3, 143.4, 133.8, 132.0, 129.7, 128.9, 126.9, 118.1, 113.2, 57.9, 
55.4, 39.6, 27.2, 8.0; IR (Neat Film, NaCl) 3075, 3004, 2971, 2938, 2839, 1667, 1600, 1574, 
1508, 1496, 1459, 1445, 1417, 1307, 1258, 1238, 1174, 1142, 1033, 998, 916, 837, 778, 750, 703 
cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H23O2 [M+H]+: 295.1693, found 295.1688; 
O
Et
EtO2C
O
Et
MeO
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SFC Conditions: 5% IPA, 2.5 mL/min, Chiralpak OJ-H column, λ = 210 nm, tR (min): minor = 
4.35, major = 4.60. 
 
 
 
 
(R)-1-(4-chlorophenyl)-2-ethyl-2-phenylpent-4-en-1-one (2j) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (57.1 mg, 
96% yield); 91% ee, [a]D25 –91.3 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.39–7.34 (m, 
4H), 7.31–7.27 (m, 1H), 7.27–7.23 (m, 2H), 7.19–7.15 (m, 2H), 5.36 (dddd, J = 16.8, 10.2, 8.2, 
6.4 Hz, 1H), 5.00–4.87 (m, 2H), 2.86–2.76 (m, 2H), 2.23–2.04 (m, 2H), 0.69 (t, J = 7.4 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 201.9, 142.5, 138.1, 135.4, 133.3, 131.0, 129.1, 128.4, 127.3, 
126.9, 118.5, 58.2, 39.2, 26.9, 8.0; IR (Neat Film, NaCl) 3074, 2973, 2940, 2878, 1677, 1640, 
1586, 1486, 1446, 1398, 1225, 1178, 1093, 1001, 917, 827, 775, 744, 703 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C19H20ClO [M+H]+: 299.1197, found 299.1201; SFC 
Conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 
6.09, major = 6.64. 
O
Et
Cl
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(R)-2-ethyl-1-(4-fluorophenyl)-2-phenylpent-4-en-1-one (2k) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (54.1 mg, 
96% yield); 91% ee, [α]D25 –111.7 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.50–7.43 (m, 
2H), 7.40–7.31 (m, 2H), 7.32–7.23 (m, 3H), 6.91–6.82 (m, 2H), 5.37 (dddd, J = 16.8, 10.2, 8.2, 
6.4 Hz, 1H), 5.00–4.87 (m, 2H), 2.91–2.72 (m, 2H), 2.27–1.97 (m, 2H), 0.69 (t, J = 7.5 Hz, 3H); 
19F NMR (282 MHz) δ –107.1 (tt, J = 8.5, 5.5 Hz); 13C NMR (100 MHz, CDCl3) δ 201.5, 164.7 
(d, J = 253.6 Hz), 142.7, 133.4, 133.3 (d, J = 3.3 Hz), 132.2 (d, J = 8.9 Hz), 129.1, 127.2, 126.9, 
118.4, 115.1 (d, J = 21.5 Hz), 58.1, 39.3, 27.0, 8.0; IR (Neat Film, NaCl) 3076, 2973, 2940, 
1677, 1639, 1598, 1504, 1446, 1231, 1158, 1143, 1000, 917, 841, 777, 747, 704 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C19H20FO [M+H]+: 283.1493, found 283.1479; SFC Conditions 
(on cross-metathesis pdt, see pg S35): 5% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 
nm, tR (min): minor = 7.43, major = 8.03. 
 
O
Et
F
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(R)-2-ethyl-2-phenyl-1-(4-(trifluoromethyl)phenyl)pent-4-en-1-one (2l) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (65.5 mg, 
99% yield); 90% ee, [α]D25 –95.1 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.47 (s, 4H), 
7.41–7.36 (m, 2H), 7.34–7.29 (m, 1H), 7.29–7.25 (m, 2H), 5.37 (ddt, J = 17.0, 10.2, 7.3 Hz, 1H), 
5.02 4.87 (m, 2H), 2.83 (dt, J = 7.3, 1.2 Hz, 2H), 2.26–2.05 (m, 2H), 0.70 (t, J = 7.4 Hz, 3H); 19F 
NMR (282 MHz) δ –63.2 (s); 13C NMR (100 MHz, CDCl3) δ  202.4, 141.9, 140.3, 133.1, 133.1 
(q, J = 32.6 Hz) 129.7, 129.2, 127.5, 126.9, 125.1 (q, J = 3.7 Hz), 123.7 (q, J = 272.5) 118.6, 
58.4, 39.0, 26.7, 7.9; IR (Neat Film, NaCl) 3078, 2974, 2942, 2880, 1683, 1641, 1599, 1580, 
1494, 1461, 1446, 1407, 1326, 1227, 1170, 1131, 1069, 1016, 1001, 918, 849, 834, 781, 754, 702 
cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H23F3NO [M+NH4]+: 350.1726, found 
350.1723; SFC Conditions (on cross-metathesis pdt, see pg S36): 5% IPA, 2.5 mL/min, 
Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 4.47, major = 5.90. 
 
 
 
 
 
(R)-2-ethyl-1-(3-methoxyphenyl)-2-phenylpent-4-en-1-one (2m) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (55.9 mg, 
95% yield); 91% ee, [α]D25 –89.4 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.39–7.34 (m, 
2H), 7.31–7.26 (m, 3H), 7.09 (ddd, J = 8.2, 7.4, 0.7 Hz, 1H), 7.00–6.96 (m, 2H), 6.90 (ddd, J = 
8.2, 2.5, 1.2 Hz, 1H), 5.38 (dddd, J = 16.8, 10.3, 8.2, 6.4 Hz, 1H), 5.04–4.87 (m, 2H), 3.62 (s, 
3H), 2.98–2.74 (m, 2H), 2.16 (q, J = 7.5 Hz, 2H), 0.70 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 203.1, 159.1, 142.8, 138.5, 133.6, 129.0, 129.0, 127.1, 127.0, 122.1, 118.4, 118.3, 
113.9, 58.2, 55.3, 39.2, 26.9, 8.0; IR (Neat Film, NaCl) 3074, 2970, 2940, 1677, 1640, 1596, 
O
Et
F3C
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1580, 1487, 1462, 1446, 1425, 1318, 1288, 1258, 1206, 1180, 1046, 917, 790, 773, 738, 703 
cm1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H23O2 [M+H]+: 295.1693, found 295.1681; 
SFC Conditions: 2% IPA, 2.5 mL/min, Chiralcel OJ-H column, λ = 210 nm, tR (min): minor = 
5.57, major = 5.95. 
 
 
 
 
(R)-2-ethyl-2-phenyl-1-(o-tolyl)pent-4-en-1-one (2n) 
Purified by column chromatography (3% Et2O in hexanes) to provide a colorless oil (53.0 mg, 
95% yield); 73% ee, [α]D25 –62.0 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.30–7.24 (m, 
4H), 7.22–7.15 (m, 1H), 7.11–7.04 (m, 2H), 6.74 (dtd, J = 8.6, 4.0, 0.7 Hz, 1H), 6.54 (dt, J = 7.8, 
1.0 Hz, 1H), 5.35 (dddd, J = 16.9, 10.3, 7.9, 6.6 Hz, 1H), 4.92–4.75 (m, 2H), 2.75 (ddt, J = 7.9, 
6.9, 1.3 Hz, 2H), 2.26 (s, 3H), 2.14–1.87 (m, 2H), 0.62 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 207.2, 141.9, 138.3, 138.1, 133.7, 131.9, 130.0, 128.9, 127.6, 127.1, 127.0, 124.6, 
118.2, 58.7, 38.5, 26.7, 21.1, 7.9; IR (Neat Film, NaCl) 3061, 2972, 2939, 2879, 1680, 1640, 
1599, 1493, 1456, 1446, 1381, 1287, 1226, 1121, 997, 916, 847, 764, 755, 734, 702, 652 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C20H23O [M+H]+: 279.1743, found 279.1746; SFC 
O
Et
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Conditions (on cross metathesis pdt, see pg S37): 10% IPA, 2.5 mL/min, Chiralpak IC column, λ 
= 210 nm, tR (min): minor = 5.74, major = 6.49. 
 
 
(R)-2-ethyl-1-phenyl-2-(p-tolyl)pent-4-en-1-one (2o) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (53.5 mg, 
96% yield); 91% ee, [α]D25 –107.3 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.44–7.41 (m, 
2H), 7.37–7.33 (m, 1H), 7.23–7.18 (m, 2H), 7.17 (s, 4H), 5.38 (dddd, J = 16.8, 10.2, 8.2, 6.4 Hz, 
1H), 5.01–4.84 (m, 2H), 2.92–2.74 (m, 2H), 2.35 (s, 3H), 2.20–2.03 (m, 2H), 0.68 (t, J = 7.5 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 203.6, 139.5, 137.5, 136.7, 133.8, 131.7, 129.7, 129.5, 
128.0, 126.8, 118.1, 57.8, 39.2, 26.9, 21.2, 8.0; IR (Neat Film, NaCl) 3069, 2973, 2878, 1676, 
1640, 1597, 1578, 1514, 1446, 1228, 1182, 1143, 1020, 1004, 914, 815, 779, 734, 708, 692 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C20H23O [M+H]+: 279.1743, found 279.1733; SFC 
Conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 7.07, 
major = 8.66. 
 
 
 
O
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(R)-2-ethyl-2-(4-methoxyphenyl)-1-phenylpent-4-en-1-one (2p) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (59.0 mg, 
99% yield); 92% ee, [α]D25 –109.6 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.45–7.31 (m, 
3H), 7.24–7.16 (m, 4H), 6.94–6.87 (m, 2H), 5.39 (dddd, J = 16.9, 10.3, 8.0, 6.6 Hz, 1H), 5.04–
4.80 (m, 2H), 3.81 (s, 3H), 2.80 (ddt, J = 6.7, 5.7, 1.2 Hz, 2H), 2.26–2.01 (m, 2H), 0.68 (t, J = 
7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.6, 158.6, 137.5, 134.5, 133.7, 131.6, 129.5, 
128.1, 128.0, 118.1, 114.3, 57.4, 55.3, 39.3, 26.9, 8.0; IR (Neat Film, NaCl) 3069, 2970, 2836, 
1674, 1639, 1609, 1578, 1513, 1262, 1445, 1295, 1251, 1229, 1182, 1143, 1035, 1004, 915, 827, 
781, 741, 709, 693 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H23O2 [M+H]+: 295.1693, 
found 295.1683; SFC Conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR 
(min): minor = 9.85, major = 11.03 
 
 
 
O
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(R)-2-(4-chlorophenyl)-2-ethyl-1-phenylpent-4-en-1-one (2q) 
Purified by column chromatography (3% Et2O in hexanes) to provide a colorless oil (59.1 mg, 
99% yield); 86% ee, [α]D25 –92.7 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.44–7.40 (m, 
2H), 7.40–7.36 (m, 1H), 7.36–7.32 (m, 2H), 7.25–7.19 (m, 4H), 5.36 (dddd, J = 16.8, 10.2, 8.3, 
6.4 Hz, 1H), 5.02–4.84 (m, 2H), 2.89–2.67 (m, 2H), 2.13 (q, J = 7.4 Hz, 2H), 0.69 (t, J = 7.4 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 202.7, 141.4, 136.9, 133.1, 133.0, 132.0, 129.5, 129.2, 
128.3, 128.2, 118.7, 57.8, 39.3, 27.0, 8.0; IR (Neat Film, NaCl) 3071, 2972, 2940, 2879, 1676, 
1596, 1492, 1446, 1402, 1227, 1181, 1096, 1014, 1004, 917, 821, 784, 725, 691 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C19H20ClO [M+H]+: 299.1197, found 299.1187; SFC 
Conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 7.08, 
major = 8.41. 
 
 
 
 
O
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(R)-2-ethyl-2-(4-fluorophenyl)-1-phenylpent-4-en-1-one (2r) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (55.3 mg, 
98% yield); 90% ee, [α]D25 –104.7 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.43–7.35 (m, 
3H), 7.26–7.19 (m, 4H), 7.09–7.03 (m, 2H), 5.36 (dddd, J = 16.8, 10.2, 8.2, 6.4 Hz, 1H), 5.05–
4.84 (m, 2H), 2.90–2.71 (m, 2H), 2.14 (q, J = 7.4 Hz, 2H), 0.69 (t, J = 7.4 Hz, 3H); 19F NMR 
(282 MHz) δ –115.6 (tt, J = 8.4, 5.2 Hz); 13C NMR (100 MHz, CDCl3) δ 203.0, 161.9 (d, J = 
246.2 Hz), 138.5 (d, J = 3.4 Hz), 137.1, 133.3, 131.9, 129.5, 128.5 (d, J = 7.9 Hz), 128.1, 118.5, 
115.9 (d, J = 21.2 Hz), 57.7, 39.4, 27.1, 8.0; IR (Neat Film, NaCl) 3073, 2974, 2880, 1675, 1598, 
1510, 1446, 1230, 1164, 1004, 917, 829, 816, 782, 737, 707, 692 cm–1; HRMS (MM:ESI-
APCI+) m/z calc’d for C19H20FO [M+H]+: 283.1493, found 283.1491; SFC Conditions: 5% IPA, 
2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 4.07, major = 4.47. 
 
 
 
O
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(R)-2-ethyl-1-phenyl-2-(4-(trifluoromethyl)phenyl)pent-4-en-1-one (2s) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (65.7 mg, 
99% yield); 70% ee, [α]D25 –57.1 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.63 (m, 2H), 
7.45–7.35 (m, 5H), 7.25–7.20 (m, 2H), 5.35 (dddd, J = 16.8, 10.2, 8.3, 6.5 Hz, 1H), 5.05–4.85 
(m, 2H), 3.01–2.71 (m, 2H), 2.19 (q, J = 7.4 Hz, 2H), 0.71 (t, J = 7.5 Hz, 3H); 19F NMR (282 
MHz) δ –62.5 (s); 13C NMR (126 MHz, CDCl3) δ 202.2, 147.1 (d, J = 1.4 Hz), 136.6, 132.8, 
132.2, 129.5, 129.3 (q, J = 32.9 Hz), 128.3, 127.3, 125.9 (q, J = 3.7 Hz), 124.2 (q, J = 272.1 Hz) 
118.9, 58.3, 39.4, 27.1, 8.0; IR (Neat Film, NaCl) 3075, 2975, 2942, 1678, 1641, 1617, 1597, 
1579, 1447, 1411, 1328, 1228, 1168, 1127, 1070, 1017, 920, 828, 712, 656 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C20H20F3O [M+H]+: 333.1461, found 333.1455; SFC 
Conditions: 5% IPA, 3.0 mL/min, Chiralpak AD-H column (2 columns combined), λ = 210 nm, 
tR (min): minor = 3.59, major = 3.76. 
 
 
 
O
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(R)-2-ethyl-2-(3-methoxyphenyl)-1-phenylpent-4-en-1-one (2t) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (56.1 mg, 
95% yield); 90% ee, [α]D25  –103.0 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.48–7.42 
(m, 2H), 7.39–7.33 (m, 1H), 7.31–7.27 (m, 1H), 7.25–7.17 (m, 2H), 6.90–6.79 (m, 3H), 5.38 
(dddd, J = 16.8, 10.3, 8.0, 6.6 Hz, 1H), 5.02–4.82 (m, 2H), 3.78 (s, 3H), 2.90–2.70 (m, 2H), 
2.25–2.04 (m, 2H), 0.68 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.2, 160.1, 144.4, 
137.3, 133.6, 131.8, 129.9, 129.4, 128.1, 119.5, 118.2, 113.1, 112.0, 58.1, 55.3, 39.2, 26.9, 8.0; 
IR (Neat Film, NaCl) 3070, 2971, 2939, 2878, 2835, 1676, 1640, 1598, 1581, 1487, 1462, 1446, 
1433, 1292, 1261, 1229, 1168, 1050, 1004, 917, 776, 727, 701 cm–1; HRMS (MM:ESI-APCI+) 
m/z calc’d for C20H23O2 [M+H]+: 295.1693, found 295.1683; SFC Conditions: 5% IPA, 3.0 
mL/min, Chiralpak AD-H column (2 columns combined), λ = 210 nm, tR (min): minor = 7.91, 
major = 8.48. 
 
 
 
O
Et
OMe
Supporting Information for Alexy, Zhang, and Stoltz 	
 
S21 
 
 
(R)-2-ethyl-1-phenyl-2-(o-tolyl)pent-4-en-1-one (2u) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (55.9 mg, 
99% yield); 90% ee, [α]D25 –100.6 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.63–7.58 (m, 
2H), 7.51–7.48 (m, 1H), 7.41–7.35 (m, 1H), 7.33–7.28 (m, 1H), 7.22–7.16 (m, 3H), 7.07–7.02 
(m, 1H), 5.34 (ddt, J = 17.5, 10.3, 7.4 Hz, 1H), 5.06–4.84 (m, 2H), 2.93–2.86 (m, 2H), 2.28 (dt, J 
= 14.8, 7.4 Hz, 1H), 2.14 (dt, J = 13.9, 7.3 Hz, 1H), 2.09 (s, 3H), 0.69 (t, J = 7.4 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 203.1, 141.4, 136.7, 133.9, 132.7, 132.3, 129.1, 128.1, 127.1, 126.6, 
126.4, 118.2, 57.9, 37.3, 26.6, 21.1, 8.1; IR (Neat Film, NaCl) 3068, 2975, 2879, 1674, 1639, 
1596, 1578, 1487, 1446, 1384, 1225, 1181, 1136, 1059, 1004, 915, 841, 760, 733, 710, 692 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C20H23O [M+H]+: 279.1743, found 279.1736; SFC 
Conditions: 5% IPA, 3.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 3.76, 
major = 4.05. 
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General Procedure for Preparation of Allyl Enol Carbonate Substrates 
 
 
 
To a flame-dried flask was added LHMDS (335 mg, 2 mmol) followed by toluene (3.0 mL) and 
N,N-dimethylethylamine (0.213 mL), and the resulting mixture stirred at 25 °C for 5 minutes.  A 
solution of ketone (1 mmol) in toluene (2.0 mL) was then added, and the reaction stirred at 25 °C 
for an additional 30 minutes.  The flask was then submerged in a room temperature water bath, 
and allyl chloroformate (0.217 mL, 2 mmol) was added neat, and the reaction continued until no 
starting material remained by TLC (typically less than 30 minutes).  The crude reaction mixture 
was diluted with Et2O and quenched with water.  The layers were separated, and the aqueous 
layer was extracted with Et2O twice.  The combined organic layers were dried over Na2SO4 and 
concentrated.  The crude product was purified by silica gel flash chromatography to afford the 
desired enol carbonate.  The E/Z ratio of enol carbonates was determined by 1H NMR and is 
>95:5 unless stated otherwise. 
 
 
 
 
(E)-allyl (1,2-diphenylbut-1-en-1-yl) carbonate (1a) 
Run on 2.0 mmol scale. Purified by column chromatography (8% Et2O in hexanes) to provide a 
colorless oil (586.3 mg, 95% yield); 1H NMR (500 MHz, CDCl3) δ 7.23–7.17 (m, 3H), 7.14–
7.10 (m, 7H), 5.93 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.40–5.22 (m, 2H), 4.64 (dt, J = 5.7, 1.4 Hz, 
2H), 2.58 (q, J = 7.5 Hz, 2H), 0.99 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 153.2, 
142.9, 138.9, 135.1, 133.3, 131.3, 129.5, 128.9, 128.2, 127.8, 127.8, 127.0, 119.0, 68.9, 26.0, 
Ar1
O
Ar2
R
LHMDS (2 equiv)
Me2NEt (2 equiv)
toluene, 25 °C
then allyl chloroformate Ar1
O
Ar2
R
O
O
O O
O
Et
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12.2; IR (Neat Film, NaCl) 3083, 3057, 2972, 2936, 2875, 1756, 1651, 1600, 1577, 1493, 1445, 
1364, 1257, 1220, 1122, 1091, 1075, 1044, 988, 858, 766, 697 cm–1; HRMS (MM:ESI-APCI+) 
m/z calc’d for C20H24NO3 [M+NH4]+: 326.1751, found 326.1756. 
 
 
(E)-allyl (1,2-diphenylprop-1-en-1-yl) carbonate (1b) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (210.3 mg, 
71% yield, 81:17 E/Z ratio); 1H NMR major isomer (300 MHz, CDCl3) δ 7.46–7.34 (m, 1H), 
7.23–7.17 (m, 2H), 7.17–7.09 (m, 7H), 5.94 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.44–5.23 (m, 2H), 
4.65 (dt, J = 5.7, 1.4 Hz, 2H), 2.16 (s, 3H); 13C NMR major isomer (100 MHz, CDCl3) δ 153.1, 
143.6, 140.4, 135.1, 131.4, 129.1, 128.6, 128.4, 128.0, 127.4, 127.3, 127.2, 119.2, 69.0, 19.2; IR 
(Neat Film, NaCl) 3082, 3057, 3024, 2992, 2947, 1759, 1493, 1444, 1381, 1364, 1229, 1122, 
1030, 966, 777, 765, 698 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H22NO3 [M+NH4]+: 
312.1594, found 312.1583. 
 
 
(E)-allyl (1,2,3-triphenylprop-1-en-1-yl) carbonate (1c) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (305.8 mg, 
83% yield); 1H NMR (500 MHz, CDCl3) δ 7.25–7.09 (m, 13H), 7.04–6.98 (m, 2H), 5.90 (ddt, J 
= 17.2, 10.5, 5.7 Hz, 1H), 5.46–5.15 (m, 2H), 4.61 (dt, J = 5.8, 1.4 Hz, 2H), 3.91 (s, 2H); 13C 
NMR (100 MHz, CDCl3) δ 153.2, 144.4, 138.8, 138.6, 134.9, 131.3, 130.3, 129.7, 129.1, 128.4, 
128.2, 128.1, 128.0, 127.2, 126.2, 119.3, 69.1, 39.1; IR (Neat Film, NaCl) 3027, 1760, 1601, 
1495, 1444, 1364, 1227, 1118, 1030, 971, 776, 698 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d 
for C25H26NO3 [M+NH4]+: 388.1907, found 388.1898. 
O O
O
Me
O O
O
Bn
Supporting Information for Alexy, Zhang, and Stoltz 	
 
S24 
 
 
(E)-allyl (1,2-diphenylhex-1-en-1-yl) carbonate (1d) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (301.3 mg, 
90% yield); 1H NMR (400 MHz, CDCl3) δ 7.23–7.16 (m, 3H), 7.15–7.09 (m, 7H), 5.92 (ddt, J = 
17.2, 10.4, 5.7 Hz, 1H), 5.40–5.23 (m, 2H), 4.64 (dt, J = 5.7, 1.4 Hz, 2H), 2.59–2.47 (m, 2H), 
1.38–1.28 (m, 4H), 0.98–0.83 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 153.3, 143.4, 139.2, 
135.2, 132.2, 131.4, 129.5, 129.0, 128.3, 127.9, 127.8, 127.1, 119.1, 69.0, 32.6, 29.6, 22.7, 14.0; 
IR (Neat Film, NaCl) 3082, 3057, 3024, 2957, 2930, 2861, 1760, 1493, 1444, 1380, 1364, 1292, 
1240, 1227, 1207, 1122, 1000, 964, 772, 698 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C22H28NO3 [M+NH4]+: 354.2064, found 354.2047. 
 
 
 
(E)-allyl (3-cyclopropyl-1,2-diphenylprop-1-en-1-yl) carbonate (1e) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (299.4 mg, 
90% yield); 1H NMR (500 MHz, CDCl3) δ 7.24–7.09 (m, 10H), 5.92 (ddt, J = 17.2, 10.4, 5.7 Hz, 
1H), 5.39–5.22 (m, 2H), 4.63 (dt, J = 5.7, 1.4 Hz, 2H), 2.47 (d, J = 6.9 Hz, 2H), 0.78–0.67 (m, 
1H), 0.41–0.31 (m, 2H), 0.13 – -0.03 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 153.3, 143.3, 
139.6, 135.1, 131.9, 131.4, 129.6, 129.0, 128.2, 127.9, 127.0, 119.2, 69.0, 37.5, 9.6, 4.7; IR (Neat 
Film, NaCl) 3079, 3003, 2950, 1760, 1491, 1444, 1364, 1292, 1247, 1222, 1127, 1056, 1018, 
972, 936, 826, 771, 698 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C22H26NO3 [M+NH4]+: 
352.1907, found 352.1903. 
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(E)-allyl (4,4,4-trifluoro-1,2-diphenylbut-1-en-1-yl) carbonate (1f) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (299.0 mg, 
82% yield); 1H NMR (400 MHz, CDCl3) δ 7.24–7.19 (m, 3H), 7.19–7.11 (m, 7H), 5.90 (ddt, J = 
17.2, 10.4, 5.8 Hz, 1H), 5.44–5.21 (m, 2H), 4.62 (dt, J = 5.8, 1.4 Hz, 2H), 3.40 (q, J = 10.3 Hz, 
2H); 19F NMR (282 MHz, CDCl3) δ –63.1 (t, J = 10.4 Hz); 13C NMR (100 MHz, CDCl3) δ 
152.5, 148.5, 137.7, 134.1, 131.0, 129.6, 129.1, 128.8, 128.6, 128.1, 127.8, 125.7 (q, J = 278.5 
Hz), 120.6 (q, J = 2.6 Hz), 119.6, 69.4, 37.3 (q, J = 30.0 Hz); IR (Neat Film, NaCl) 3085, 3059, 
3026, 1764, 1651, 1494, 1446, 1258, 1224, 1136, 1110, 1056, 972, 956, 940, 777, 700 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C20H21F3NO3 [M+NH4]+: 380.1468, found 380.1455. 
 
 
 
 
(E)-allyl (2-phenyl-1-(p-tolyl)but-1-en-1-yl) carbonate (1g) 
Purified by column chromatography (4% Et2O in hexanes) to provide a colorless oil (291.6 mg, 
90% yield); 1H NMR (300 MHz, CDCl3) δ 7.25–7.17 (m, 3H), 7.16–7.10 (m, 2H), 7.04–6.98 (m, 
2H), 6.96–6.89 (m, 2H), 5.93 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.42–5.23 (m, 2H), 4.64 (dt, J = 
5.7, 1.4 Hz, 2H), 2.56 (q, J = 7.5 Hz, 2H), 2.23 (s, 3H), 0.97 (t, J = 7.5 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 153.4, 143.1, 139.2, 137.7, 132.7, 132.2, 131.5, 129.6, 128.8, 128.7, 128.3, 
127.0, 119.2, 69.0, 26.1, 21.4, 12.3; IR (Neat Film, NaCl) 3082, 3055, 3026, 2972, 2875, 1760, 
1650, 1511, 1491, 1443, 1308, 1291, 1258, 1226, 1184, 1122, 1089, 1045, 988, 946, 929, 862, 
826, 784, 768, 701 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H26NO3 [M+NH4]+: 
340.1907, found 340.1896. 
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ethyl (E)-4-(1-(((allyloxy)carbonyl)oxy)-2-phenylbut-1-en-1-yl)benzoate (1h) 
Purified by column chromatography (8% Et2O in hexanes) to provide a colorless oil (291.2 mg, 
77% yield); 1H NMR (300 MHz, CDCl3) δ 7.82–7.74 (m, 2H), 7.25–7.15 (m, 5H), 7.14–7.05 (m, 
2H), 5.92 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.48–5.20 (m, 2H), 4.64 (dt, J = 5.8, 1.4 Hz, 2H), 
4.31 (q, J = 7.1 Hz, 2H), 2.59 (q, J = 7.5 Hz, 2H), 1.33 (t, J = 7.1 Hz, 3H), 0.98 (t, J = 7.5 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 166.3, 153.2, 142.0, 139.7, 138.5, 135.4, 131.2, 129.5, 
129.4, 129.2, 128.8, 128.5, 127.5, 119.4, 69.2, 61.0, 26.3, 14.4, 12.2; IR (Neat Film, NaCl) 3081, 
3057, 2978, 2937, 2876, 1761, 1718, 1609, 1444, 1407, 1366, 1276, 1224, 1180, 1125, 1108, 
1045, 1022, 990, 947, 860, 769, 702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C23H28NO5 
[M+NH4]+: 398.1962, found 398.1952. 
 
 
(E)-allyl (1-(4-methoxyphenyl)-2-phenylbut-1-en-1-yl) carbonate (1i) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (254.3 mg, 
75% yield); 1H NMR (300 MHz, CDCl3) δ 7.25–7.16 (m, 3H), 7.16–7.10 (m, 2H), 7.09–7.01 (m, 
2H), 6.72–6.58 (m, 2H), 5.94 (ddt, J = 17.3, 10.5, 5.7 Hz, 1H), 5.49–5.20 (m, 2H), 4.64 (dt, J = 
5.7, 1.4 Hz, 2H), 3.72 (s, 3H), 2.55 (q, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 159.0, 153.4, 142.9, 139.2, 132.1, 131.5, 130.3, 129.6, 128.3, 127.6, 127.0, 
119.2, 113.3, 69.0, 55.2, 26.0, 12.3; IR (Neat Film, NaCl) 2970, 2936, 1760, 1651, 1609, 1576, 
1511, 1462, 1443, 1364, 1294, 1252, 1226, 1176, 1123, 1044, 1014, 988, 946, 862, 836, 784, 
767, 701 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H26NO4 [M+NH4]+: 356.1856, found 
356.1845. 
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(E)-allyl (1-(4-chlorophenyl)-2-phenylbut-1-en-1-yl) carbonate (1j) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (310.0 mg, 
90% yield); 1H NMR (300 MHz, CDCl3) δ 7.22 (dd, J = 5.3, 1.9 Hz, 3H), 7.14–7.00 (m, 6H), 
6.04–5.82 (m, 1H), 5.45–5.24 (m, 2H), 4.64 (dd, J = 5.7, 1.5 Hz, 2H), 2.56 (q, J = 7.5 Hz, 2H), 
0.97 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 153.3, 141.9, 138.6, 134.2, 133.7, 133.6, 
131.3, 130.3, 129.5, 128.5, 128.2, 127.4, 119.4, 69.2, 26.1, 12.2; IR (Neat Film, NaCl) 3081, 
3057, 2972, 2936, 2875, 1760, 1649, 1594, 1490, 1443, 1364, 1292, 1275, 1257, 1224, 1180, 
1123, 1092, 1045, 1015, 989, 946, 930, 860, 835, 768, 701 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C20H23ClNO3 [M+NH4]+: 360.1361, found 360.1372. 
 
 
 
(E)-allyl (1-(4-fluorophenyl)-2-phenylbut-1-en-1-yl) carbonate (1k) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil which 
solidifies in a freezer (303.7 mg, 93% yield); 1H NMR (500 MHz, CDCl3) δ 7.25–7.18 (m, 3H), 
7.10 (ddq, J = 5.3, 4.6, 2.9 Hz, 4H), 6.85–6.74 (m, 2H), 5.93 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 
5.50–5.14 (m, 2H), 4.64 (dt, J = 5.7, 1.4 Hz, 2H), 2.56 (q, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 
3H); 19F NMR (282 MHz) δ –113.3 (m); 13C NMR (100 MHz, CDCl3) δ 162.1 (d, J = 248.1 Hz), 
153.3, 142.1, 138.8, 133.6, 131.3, 131.3, 130.9 (d, J = 8.3 Hz), 129.5, 128.4, 127.2, 119.3, 115.0 
(d, J = 21.6 Hz), 69.1, 26.0, 12.2; IR (Neat Film, NaCl) 3081, 3058, 3024, 2973, 2937, 2876, 
1760, 1651, 1605, 1444, 1364, 1292, 1259, 1225, 1159, 1122, 1096, 1045, 989, 946, 930, 864, 
842, 809, 785, 767, 701 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H23FNO3 [M+NH4]+: 
344.1656, found 344.1659. 
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(E)-allyl (2-phenyl-1-(4-(trifluoromethyl)phenyl)but-1-en-1-yl) carbonate (1l) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil which 
solidifies in a freezer (354.0 mg, 94% yield); 1H NMR (300 MHz, CDCl3) δ 7.40–7.33 (m, 2H), 
7.25–7.19 (m, 5H), 7.15–7.06 (m, 2H), 5.93 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.48–5.15 (m, 2H), 
4.65 (dt, J = 5.8, 1.4 Hz, 2H), 2.59 (q, J = 7.5 Hz, 2H), 0.98 (t, J = 7.5 Hz, 3H); 19F NMR (282 
MHz) δ –62.8 (s); 13C NMR (100 MHz, CDCl3) δ 153.3, 141.6, 138.8, 138.3, 135.6, 131.2, 129.6 
(q, J = 32.4 Hz), 129.4, 129.1, 128.6, 127.6, 124.9 (q, J = 3.8 Hz), 124.1 (q, J = 271.6 Hz), 
119.5, 69.3, 26.3, 12.1; IR (Neat Film, NaCl) 3083, 2059, 3025, 2975, 2938, 2878, 1760, 1651, 
1618, 1577, 1492, 1444, 1408, 1365, 1327, 1292, 1260, 1226, 1168, 1127, 1068, 1046, 1018, 
989, 946, 931, 847, 782, 769, 702, 613 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C21H23F3NO3 [M+NH4]+: 394.1625, found 394.1608 
 
 
(E)-allyl (1-(3-methoxyphenyl)-2-phenylbut-1-en-1-yl) carbonate (1m) 
Purified by column chromatography (10% Et2O in hexanes) to provide a colorless oil (320.2 mg, 
95% yield); 1H NMR (300 MHz, CDCl3) δ 7.25–7.18 (m, 3H), 7.17–7.11 (m, 2H), 7.04 (ddd, J = 
8.2, 7.7, 0.4 Hz, 1H), 6.78–6.59 (m, 3H), 5.94 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.47–5.20 (m, 
2H), 4.65 (dt, J = 5.7, 1.4 Hz, 2H), 3.51 (s, 3H), 2.56 (q, J = 7.5 Hz, 2H), 0.98 (t, J = 7.5 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 158.9, 153.4, 142.8, 139.1, 136.3, 133.5, 131.4, 129.5, 
128.9, 128.4, 127.2, 121.1, 119.2, 114.5, 114.0, 69.1, 55.1, 26.2, 12.2; IR (Neat Film, NaCl) 
2970, 2937, 1760, 1600, 1580, 1486, 1464, 1454, 1444, 1428, 1364, 1323, 1288, 1234, 1204, 
1178, 1120, 1043, 994, 948, 892, 863, 784, 769, 701 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d 
for C21H26NO4 [M+NH4]+: 356.1856, found 356.1844 
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(E)-allyl (2-phenyl-1-(o-tolyl)but-1-en-1-yl) carbonate (1n) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (299.3 mg, 
93% yield, 80:20 E/Z ratio); 1H NMR major isomer (300 MHz, CDCl3) δ 7.41–7.28 (m, 1H), 
7.21 (dd, J = 7.6, 1.6 Hz, 1H), 7.16–7.06 (m, 4H), 7.04 – 6.97 (m, 3H), 5.91 (ddt, J = 17.2, 10.4, 
5.8 Hz, 1H), 5.41 – 5.22 (m, 2H), 4.60 (dt, J = 5.8, 1.4 Hz, 2H), 2.62 (q, J = 7.5 Hz, 2H), 2.18 (s, 
3H), 1.02 (t, J = 7.5 Hz, 3H); 13C NMR major isomer (100 MHz, CDCl3) δ 153.1, 142.9, 138.5, 
137.5, 134.4, 134.3, 131.5, 131.5, 130.0, 129.0, 128.5, 127.9, 126.9, 125.2, 119.2, 68.9, 25.1, 
20.0, 12.9; IR (Neat Film, NaCl) 3022, 2971, 1758, 1493, 1457, 1443, 1380, 1364, 1292, 1258, 
1225, 1131, 1044, 988, 946, 862, 769, 700 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C21H26NO3 [M+NH4]+: 340.1907, found 340.1892. 
 
 
 
(E)-allyl (1-phenyl-2-(p-tolyl)but-1-en-1-yl) carbonate (1o) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (295.7 mg, 
92% yield); 1H NMR (500 MHz, CDCl3) δ 7.15 – 7.11 (m, 5H), 7.03–6.99 (m, 4H), 5.93 (ddt, J 
= 17.2, 10.4, 5.7 Hz, 1H), 5.41–5.24 (m, 2H), 4.64 (dt, J = 5.7, 1.4 Hz, 2H), 2.56 (q, J = 7.5 Hz, 
2H), 2.30 (s, 3H), 0.98 (t, J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 153.4, 142.7, 136.8, 
135.9, 135.3, 133.3, 131.4, 129.4, 129.1, 129.0, 127.9, 127.8, 119.2, 69.0, 26.1, 21.3, 12.3; IR 
(Neat Film, NaCl) 3024, 2971, 2935, 2874, 1760, 1512, 1292, 1445, 1364, 1291, 1258, 1224, 
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1122, 1044, 988, 946, 928, 818, 778, 697 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C21H23O3 [M+H]+: 323.1642, found 323.1630. 
 
 
(E)-allyl (2-(4-methoxyphenyl)-1-phenylbut-1-en-1-yl) carbonate (1p) 
Purified by column chromatography (8% Et2O in hexanes) to provide a colorless oil (295.0 mg, 
87% yield); 1H NMR (500 MHz, CDCl3) δ 7.16–7.11 (m, 5H), 7.07–7.00 (m, 2H), 6.78–6.71 (m, 
2H), 5.93 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.40–5.23 (m, 2H), 4.64 (dt, J = 5.7, 1.4 Hz, 2H), 
3.77 (s, 3H), 2.55 (q, J = 7.5 Hz, 2H), 0.98 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
158.7, 153.4, 142.6, 135.4, 132.9, 131.4, 131.1, 130.7, 129.0, 127.9, 127.7, 119.2, 113.8, 69.0, 
55.3, 26.1, 12.3; IR (Neat Film, NaCl) 2970, 1758, 1650, 1608, 1574, 1511, 1493, 1462, 1444, 
1364, 1289, 1245, 1223, 1177, 1122, 1044, 987, 831, 778, 698 cm–1; HRMS (MM:ESI-APCI+) 
m/z calc’d for C21H23O4 [M+H]+: 339.1591, found 339.1574. 
 
 
 
(E)-allyl (2-(4-chlorophenyl)-1-phenylbut-1-en-1-yl) carbonate (1q) 
Purified by column chromatography (8% Et2O in hexanes) to provide a colorless oil which 
solidifies in a freezer (315.0 mg, 92% yield); 1H NMR (500 MHz, CDCl3) δ 7.20–7.10 (m, 7H), 
7.07–7.02 (m, 2H), 5.92 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.46–5.19 (m, 2H), 4.64 (dt, J = 5.7, 
1.4 Hz, 2H), 2.56 (q, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
153.2, 143.5, 137.5, 134.8, 133.0, 132.2, 131.3, 131.0, 129.1, 128.6, 128.1, 128.1, 119.3, 69.1, 
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25.9, 12.2; IR (Neat Film, NaCl) 2973, 2936, 1760, 1490, 1445, 1364, 1292, 1256, 1224, 1123, 
1090, 1043, 988, 947, 928, 861, 828, 774, 697 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C20H20ClO3 [M+H]+: 343.1095, found 343.1087. 
 
(E)-allyl (2-(4-fluorophenyl)-1-phenylbut-1-en-1-yl) carbonate (1r) 
Purified by column chromatography (6% Et2O in hexanes) to provide a colorless oil (305.7 mg, 
94% yield); 1H NMR (500 MHz, CDCl3) δ 7.16–7.10 (m, 5H), 7.10–7.05 (m, 2H), 6.93–6.85 (m, 
2H), 5.92 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.46–5.16 (m, 2H), 4.64 (dt, J = 5.7, 1.4 Hz, 2H), 
2.56 (q, J = 7.5 Hz, 2H), 0.98 (t, J = 7.5 Hz, 3H); 19F NMR (282 MHz, CDCl3) δ –115.1 (tt, J = 
8.8, 5.5 Hz); 13C NMR (100 MHz, CDCl3) δ 162.0 (d, J = 246.2 Hz), 153.3, 143.3, 135.0, 134.8 
(d, J = 3.4 Hz), 132.4, 131.4, 131.2 (d, J = 7.9 Hz), 129.0, 128.0, 119.3, 115.4 (d, J = 21.4 Hz), 
69.1, 26.0, 12.2; IR (Neat Film, NaCl) 2973, 2936, 1759, 1602, 1508, 1445, 1364, 1292, 1259, 
1222, 1158, 1122, 1043, 988, 945, 835, 767, 698 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C20H20FO3 [M+H]+: 327.1391, found 327.1396. 
 
 
(E)-allyl (1-phenyl-2-(4-(trifluoromethyl)phenyl)but-1-en-1-yl) carbonate (1s) 
Purified by column chromatography (8% Et2O in hexanes) to provide a white solid (359.9 mg, 
96% yield); 1H NMR (500 MHz, CDCl3) δ 7.49–7.44 (m, 2H), 7.25–7.22 (m, 2H), 7.19–7.08 (m, 
5H), 5.93 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.49–5.22 (m, 2H), 4.65 (dt, J = 5.7, 1.4 Hz, 2H), 
2.60 (q, J = 7.5 Hz, 2H), 0.99 (t, J = 7.5 Hz, 3H); 19F NMR (282 MHz, CDCl3) δ –62.5 (s); 13C 
NMR (100 MHz, CDCl3) δ 153.1, 144.0, 143.0 (d, J = 1.6 Hz), 134.6, 132.2, 131.3, 130.0, 129.2 
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(q, J = 32.2 Hz), 129.1, 128.4, 128.1, 125.3 (q, J = 3.8 Hz), 124.2 (q, J = 272.1 Hz), 119.4, 69.2, 
25.9, 12.2; IR (Neat Film, NaCl) 2975, 2939, 1760, 1616, 1446, 1406, 1365, 1326, 1260, 1225, 
1166, 1125, 1109, 1067, 1044, 988, 947, 930, 839, 779, 696 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C21H23F3NO3 [M+NH4]+: 394.1625, found 394.1612. 
 
 
(E)-allyl (2-(3-methoxyphenyl)-1-phenylbut-1-en-1-yl) carbonate (1t) 
Purified by column chromatography (8% Et2O in hexanes) to provide a colorless oil (288.3 mg, 
85% yield); 1H NMR (500 MHz, CDCl3) δ 7.18–7.05 (m, 6H), 6.77–6.62 (m, 3H), 5.93 (ddt, J = 
17.2, 10.5, 5.7 Hz, 1H), 5.43–5.21 (m, 2H), 4.64 (dt, J = 5.7, 1.4 Hz, 2H), 3.66 (s, 3H), 2.56 (q, J 
= 7.5 Hz, 2H), 0.99 (t, J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 159.5, 153.3, 143.0, 
140.3, 135.2, 133.3, 131.4, 129.3, 128.9, 127.9, 122.1, 119.2, 115.0, 113.0, 69.1, 55.2, 26.0, 
12.3; IR (Neat Film, NaCl) 2970, 1759, 1598, 1577, 1486, 1463, 1446, 1427, 1260, 1225, 1180, 
1120, 1048, 988, 780, 698 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H26NO4 [M+NH4]+: 
356.1856, found 356.1845. 
 
 
(E)-allyl (1-phenyl-2-(o-tolyl)but-1-en-1-yl) carbonate (1u) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (225.3 mg, 
70% yield); 1H NMR (400 MHz, CDCl3) δ 7.21–7.04 (m, 9H), 5.96 (ddt, J = 17.2, 10.4, 5.7 Hz, 
1H), 5.47–5.19 (m, 2H), 4.68 (dq, J = 5.7, 1.2 Hz, 2H), 2.67–2.41 (m, 2H), 2.13 (d, J = 0.6 Hz, 
3H), 1.00 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 153.4, 142.7, 138.1, 136.2, 135.2, 
132.3, 131.4, 130.3, 129.7, 127.8, 127.8, 127.4, 125.8, 119.1, 69.0, 26.2, 19.6, 11.6; IR (Neat 
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Film, NaCl) 2970, 1758, 1494, 1444, 1363, 1259, 1222, 1132, 1088, 1044, 987, 918, 858, 762, 
730, 694 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H26NO3 [M+NH4]+: 340.1907, found 
340.1912. 
 
 
Derivatization of Alkylation Products 
 
 
To an oven dried vial was added the alpha-quaternary ketone (0.1 mmol) followed by CH2Cl2 
(1.0 mL) and methyl acrylate (1.0 mmol, 90 µL).  The resulting solution was stirred for five 
minutes at ambient temperature then treated with a solution of Grubb’s second generation 
catalyst (4.2 mg) in 500 µL CH2Cl2.  The reaction was then heated to 40 °C and stirred for five 
hours.  The crude reaction mixture was directly concentrated and then purified by silica gel flash 
chromatography to obtain the desired product. 
 
 
 
 
methyl (R,E)-5-(4-methylbenzoyl)-5-phenylhept-2-enoate (SI1) 
Purified by column chromatography (4% Et2O in hexanes) to provide a white solid (25.4 mg, 
76% yield; 90% ee, [α]D25 –117.37 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.39–7.32 (m, 
4H), 7.32–7.24 (m, 3H), 7.04–6.99 (m, 2H), 6.56 (ddd, J = 15.5, 9.0, 6.4 Hz, 1H), 5.71 (ddd, J = 
15.5, 1.7, 1.1 Hz, 1H), 3.67 (s, 3H), 2.99 (ddd, J = 14.5, 9.1, 1.2 Hz, 1H), 2.86 (ddt, J = 14.6, 6.4, 
1.3 Hz, 1H), 2.29 (s, 3H), 2.27–2.12 (m, 2H), 0.72 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 201.9, 166.6, 145.1, 142.7, 142.3, 133.9, 129.7, 129.2, 128.9, 127.4, 126.8, 124.0, 58.2, 
51.6, 38.8, 26.9, 21.6, 8.2; IR (Neat Film, NaCl) 2970, 2949, 1724, 1672, 1606, 1495, 1446, 
1435, 1335, 1270, 1199, 1183, 1167, 1140, 1036, 1000, 969, 854, 821, 773, 740, 702 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C22H25O3 [M+H]+: 337.1798, found 337.1785; SFC 
Conditions: 5% IPA, 2.5 mL/min, Chiralcel OB-H column, λ = 210 nm, tR (min): minor = 4.14, 
major = 4.95. 
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ethyl (R,E)-4-(2-ethyl-6-methoxy-6-oxo-2-phenylhex-4-enoyl)benzoate (6) 
Purified by column chromatography (7% Et2O in hexanes) to provide a white solid (34.8 mg, 
88% yield; 90%, [α]D25 –113.62 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.90–7.85 (m, 
2H), 7.45–7.36 (m, 4H), 7.35–7.27 (m, 3H), 6.54 (ddd, J = 15.5, 8.9, 6.5 Hz, 1H), 5.71 (dt, J = 
15.6, 1.5 Hz, 1H), 4.33 (q, J = 7.2 Hz, 2H), 3.67 (s, 3H), 3.02–2.82 (m, 2H), 2.17 (q, J = 7.4 Hz, 
2H), 1.35 (t, J = 7.1 Hz, 3H), 0.72 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 202.2, 
166.5, 165.8, 144.4, 141.3, 140.3, 133.2, 129.4, 129.4, 129.3, 127.8, 126.8, 124.2, 61.4, 58.5, 
51.6, 38.4, 26.5, 14.4, 8.2; IR (Neat Film, NaCl) 2974, 1723, 1681, 1657, 1495, 1446, 1436, 
1337, 1312, 1276, 1228, 1199, 1170, 1106, 1020, 1001, 867, 839, 768, 729, 703 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C24H27O5 [M+H]+: 395.1853, found 395.1870; SFC Conditions: 
7% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): minor = 9.38, major = 
10.31. 
EtO2C
O
Ph
CO2Me
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methyl (R,E)-5-(4-fluorobenzoyl)-5-phenylhept-2-enoate (SI2) 
Purified by column chromatography (10% Et2O in hexanes) to provide a white solid (28.4 mg, 
83% yield; 91% ee, [α]D25 –136.18 (c 1.00, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.50–7.43 (m, 
2H), 7.42–7.29 (m, 3H), 7.27–7.20 (m, 2H), 6.94–6.83 (m, 2H), 6.54 (ddd, J = 15.5, 9.1, 6.5 Hz, 
1H), 5.71 (ddd, J = 15.6, 1.7, 1.2 Hz, 1H), 3.67 (s, 3H), 3.08–2.80 (m, 2H), 2.18 (q, J = 7.4 Hz, 
2H), 0.72 (t, J = 7.4 Hz, 3H); 19F NMR (282 MHz, CDCl3) δ –106.5 (tt, J = 8.4, 5.4 Hz); 13C 
NMR (100 MHz, CDCl3) δ 200.8, 166.6, 164.8 (d, J = 254.4 Hz), 144.7, 141.9, 132.8 (d, J = 3.2 
Hz), 132.2 (d, J = 9.0 Hz), 129.4, 127.7, 126.7, 124.2, 115.3 (d, J = 21.6 Hz), 58.3, 51.6, 38.7, 
26.9, 8.2; IR (Neat Film, NaCl) 2970, 2950, 1724, 1676, 1656, 1598, 1504, 1435, 1336, 1271, 
1232, 1199, 1158, 1001, 848, 748, 703 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H22FO3 
[M+H]+: 341.1548, found 348.1534; SFC Conditions: 5% IPA, 2.5 mL/min, Chiralcel OD-H 
column, λ = 210 nm, tR (min): minor = 7.43, major = 8.03. 
F
O
Ph
CO2Me
Et
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methyl (R,E)-5-phenyl-5-(4-(trifluoromethyl)benzoyl)hept-2-enoate (SI3) 
Purified by column chromatography (10% Et2O in hexanes) to provide a white solid (32.2 mg, 
82% yield) containing 6% dimethyl fumarate as an impurity; 90% ee, [α]D25 –116.94 (c 1.00, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.48 (s, 4H), 7.43–7.37 (m, 2H), 7.36–7.31 (m, 1H), 
7.29–7.26 (m, 2H), 6.54 (ddd, J = 15.5, 9.0, 6.4 Hz, 1H), 5.78–5.66 (m, 1H), 3.67 (s, 3H), 3.04–
2.81 (m, 2H), 2.27–2.10 (m, 2H), 0.73 (t, J = 7.4 Hz, 3H); 19F NMR (282 MHz, CDCl3) δ –63.3 
(s); 13C NMR (100 MHz, CDCl3) δ 201.7, 166.5, 144.3, 141.2, 139.7, 133.3 (q, J = 32.7 Hz), 
129.7, 129.5, 127.9, 126.8, 125.3 (q, J = 3.7 Hz), 124.3, 123.6 (d, J = 272.8 Hz), 58.5, 51.6, 38.4, 
26.5, 8.2; IR (Neat Film, NaCl) 2972, 2952, 1725, 1682, 1657, 1446, 1407, 1326, 1272, 1227, 
1199, 1169, 1131, 1068, 1001, 858, 755, 702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C22H25F3NO3 [M+NH]+: 408.1781, found 408.1771; SFC Conditions: 5% IPA, 2.5 mL/min, 
Chiralpak AD-H column, λ = 210 nm, tR (min): major = 4.47, minor = 5.90. 
F3C
O
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methyl (R,E)-5-(2-methylbenzoyl)-5-phenylhept-2-enoate (SI4) 
Purified by column chromatography (7% Et2O in hexanes) to provide a colorless oil (25.8 mg, 
77% yield); 73% ee, [α]D25 –66.93 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.42–7.30 (m, 
5H), 7.20 (dd, J = 4.1, 1.0 Hz, 2H), 6.90–6.81 (m, 1H), 6.65–6.55 (m, 2H), 5.72 (dt, J = 15.6, 1.4 
Hz, 1H), 3.68 (s, 3H), 3.07–2.88 (m, 2H), 2.37 (s, 3H), 2.13 (q, J = 7.4 Hz, 2H), 0.74 (t, J = 7.4 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 206.3, 166.6, 144.9, 141.2, 138.2, 137.7, 132.1, 130.3, 
129.2, 127.6, 127.5, 126.8, 124.8, 124.0, 58.8, 51.6, 37.7, 26.7, 21.1, 8.1; IR (Neat Film, NaCl) 
3059, 3022, 2970, 2950, 1725, 1681, 1656, 1494, 1446, 1436, 1337, 1269, 1229, 1197, 1170, 
1036, 995, 763, 734, 702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C22H25O3 [M+H]+: 
337.1798, found 337.1813; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralpak IC column, λ = 
210 nm, tR (min): major = 5.74, minor = 6.49. 
O
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(R)-2-ethyl-1,2-diphenylpentane-1,4-dione (3) 
To a 20 mL vial containing alpha quaternary ketone 2a (0.2 mmol, 52.8 mg) dissolved in 5 mL 
of 9:1 DMF/H2O was added PdCl2 (0.04 mmol, 7.1 mg) and CuCl (0.4 mmol, 39.6 mg), and the 
vial sealed with a Teflon-lined septum cap.  The vial was then quickly evacuated and backfilled 
three times with a balloon of O2, and then stirred at 25 °C under a balloon of O2 for 16 h.  The 
crude reaction was then diluted with EtOAc, followed by water and brine.  The layers were 
separated, and the aqueous layer extracted with EtOAc twice.  The combined organic layers were 
dried over Na2SO4 and concentrated.  The crude product was purified by silica gel flash 
chromatography (20% Et2O in hexanes) to afford the desired product as a white, waxy solid in a 
14:1 ketone/aldehyde ratio (47.4 mg, 85% yield); [α]D25 –87.8 (c 1.00, CHCl3); 1H NMR of 
ketone (500 MHz, CDCl3) δ 7.43–7.27 (m, 8H), 7.23–7.16 (m, 2H), 3.32 (d, J = 16.2 Hz, 1H), 
3.18 (d, J = 16.2 Hz, 1H), 2.59–2.46 (m, 1H), 2.28–2.17 (m, 1H), 1.82 (s, 3H), 0.72 (t, J = 7.4 
Hz, 3H); 13C NMR of ketone (100 MHz, CDCl3) δ 207.3, 202.7, 141.4, 137.5, 131.5, 129.2, 
129.2, 128.0, 127.5, 126.9, 57.0, 47.5, 31.8, 27.2, 8.7; IR (Neat Film, NaCl) 3059, 2971, 2940, 
2880, 1716, 1682, 1598, 1579, 1495, 1462, 1446, 1415, 1361, 1260, 1229, 1214, 1180, 1033, 
Ph
O
Ph
Et
Ph
O
Ph
Et PdCl2 (20 mol %)CuCl (2 equiv)
9:1 DMF/H2O 25 °C
1 atm O2 O
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1003, 986, 913, 783, 764, 716, 703, 646 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H21O2 
[M+H]+: 281.1536, found 281.1534. 
 
 
(R)-2-ethyl-5-hydroxy-1,2-diphenylpentan-1-one (4) 
To a one dram vial was added a 1 M solution of BH3THF (0.25 mmol, 250 µL) and the vial 
cooled to 0 °C.  Cyclohexene (0.5 mmol, 51 µL) was then added neat, dropwise and the mixture 
stirred at 0 °C for 1 h. A solution of alpha quaternary ketone 2a (0.2 mmol, 52.8 mg) in 1.0 mL 
THF was then added, and the reaction was allowed to warm to room temperature and stirred for 
4 h.  Water (500 µL) was then added to the vial followed by NaBO34H2O (1 mmol, 153.9 mg) 
and the resulting mixture stirred vigorously for 18 h.  The crude reaction was diluted with Et2O 
and water, and the layers separated.  The aqueous layer was extracted with Et2O twice, and the 
combined organic layers were washed with brine, dried over Na2SO4, and concentrated.  The 
crude product was purified by preparative TLC (30% acetone in hexanes) to afford the desired 
product as a colorless oil (42.2 mg, 75% yield); [α]D25 –11.8 (c 1.00, CHCl3); 1H NMR (500 
MHz, CDCl3) δ 7.42–7.32 (m, 5H), 7.31–7.26 (m, 3H), 7.22–7.15 (m, 2H), 3.52 (td, J = 6.6, 2.4 
Hz, 2H), 2.22–2.09 (m, 4H), 1.32–1.23 (m, 2H), 0.69 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 203.9, 142.9, 137.2, 131.8, 129.4, 129.0, 128.1, 127.1, 127.0, 63.4, 58.1, 30.5, 27.1, 
27.0, 8.1; IR (Neat Film, NaCl) 3336 (br) ,3059, 2965, 2878, 1673, 1597, 1578, 1495, 1446, 
1383, 1229, 1180, 1060, 1004, 913, 761, 702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C19H23O2 [M+H]+: 283.1693, found 283.1688. 
 
 
tert-butyl (R)-(4-benzoyl-4-phenylhexyl)carbamate (5) 
In a nitrogen-filled glovebox, ketone 2a (0.1 mmol, 26.4 mg) was added to a one dram vial 
followed by THF (1 mL).  Cp2Zr(H)Cl was then added (0.1 mmol, 25.7 mg) and the resulting 
suspension stirred at room temperature for 30 minutes, at which point the reaction became a 
Ph
O
Ph
Et
Ph
O
Ph
Et BH3•THF (1.25 equiv)cyclohexene (2.5 equiv)
THF, 0 °C to 25 °C
then NaBO3•H2O
H2O
OH
Ph
O
Ph
Et
Ph
O
Ph
Et Cp2Zr(H)Cl (1 equiv);H2NOSO3H (1.5 equiv)
THF, 25 °C
then Et3N, Boc2O
N
H
Boc
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homogeneous yellow solution.  Hydroxylamine-O-sulfonic acid was then added (0.15 mmol, 
17.0 mg) and the vial removed from the glovebox and stirred at room temperature for 1 hr.  Et3N 
(0.3 mmol, 42 µL) was then added followed by Boc2O (0.3 mmol, 69 µL) and the reaction 
continued for 2 hr and then filtered through a plug of silica.  The crude product was purified via 
preparative TLC (12% Et2O in hexanes) to afford the desired product at a viscous colorless oil 
(83% yield, 31.5 mg): [α]D25 24.5 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.46–7.36 (m, 
5H), 7.33 (td, J = 6.7, 1.1 Hz, 3H), 7.29–7.19 (m, 2H), 4.41 (s, 1H), 3.21–2.96 (m, 2H), 2.16 (dq, 
J = 42.9, 9.0, 8.2 Hz, 4H), 1.46 (s, 9H), 1.22 (ddd, J = 10.1, 6.6, 2.9 Hz, 1H), 0.73 (t, J = 7.4 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 203.8, 155.9, 142.8, 137.2, 131.8, 129.4, 129.0, 128.1, 
127.1, 127.0, 79.1, 58.1, 41.0, 31.4, 28.5, 26.9, 24.1, 8.1; IR (Neat Film, NaCl) 3377 (br), 2972, 
1701, 1676, 1597, 1578, 1516, 1446, 1391, 1365, 1270, 1248, 1173, 761, 732, 703; HRMS 
(MM:ESI-APCI+) m/z calc’d for C24H32NO3 [M+H]+: 382.2377, found 382.2375. 
 
Preliminary Investigation of Fully Alkyl Quaternary Stereocenters 
 
allyl 2-cyclohexyl-3-oxo-3-phenylpropanoate (SI5) 
To a flame-dried flask containing cyclohexaneacetic acid (10 mmol, 1.4220 g), DMAP (1 mmol, 
122 mg), and EDC-HCl (11 mmol, 2.1087 g) was added CH2Cl2 (30 mL) and the resulting 
mixture stirred for 10 minutes at 25 °C.  Allyl alcohol (10 mmol, 680 µL) was then added and 
the reaction continued at 25 °C for 1 h, then diluted with water and extracted with CH2Cl2.  The 
combined organic layers were washed with brine, then dried with Na2SO4.  The crude product 
was filtered through a plug of silica and concentrated to a colorless oil (1.5733 g, 86% crude 
yield) which was then transferred to a flame-dried flask containing benzoyl chloride (8.61 mmol, 
1.0 mL) dissolved in 40 mL CH2Cl2.  The reaction was cooled to –45 °C and 1-methylimidazole 
(10.34 mmol, 824 µL) was added followed by sequential slow addition of TiCl4 (30.15 mmol, 
3.31 mL) over 20 minutes and Et3N (34.5 mmol, 4.8 mL) over 1 h.  The resulting mixture was 
stirred for 1 h at –45 °C then slowly quenched with water.  The aqueous layer was extracted with 
Et2O and the combined organic layers washed with water then brine, and dried over Na2SO4.  
The crude product was purified by silica gel flash chromatography (10% Et2O in hexanes) to 
HO
O
1. allyl alcohol, DMAP, EDC
    CH2Cl2, 25 °C
2. BzCl, 1-methylimidazole
TiCl4, Et3N
CH2Cl2, –45 °C
O
O
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afford the desired product as a colorless oil (2.2396 g, 78% yield over two steps): 1H NMR (500 
MHz, CDCl3) δ 8.04–7.96 (m, 2H), 7.62–7.53 (m, 1H), 7.51–7.40 (m, 2H), 5.81 (ddt, J = 17.2, 
10.4, 5.7 Hz, 1H), 5.28–5.07 (m, 2H), 4.57 (ddt, J = 5.8, 2.9, 1.4 Hz, 2H), 4.21 (d, J = 9.6 Hz, 
1H), 2.46–2.33 (m, 1H), 1.76 (tdt, J = 8.6, 3.5, 1.7 Hz, 1H), 1.66 (dddd, J = 12.9, 8.6, 4.2, 2.5 
Hz, 4H), 1.40–1.24 (m, 2H), 1.23–1.06 (m, 2H), 1.01–0.86 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 194.7, 168.7, 137.2, 133.6, 131.7, 128.8, 128.6, 118.6, 65.8, 60.5, 38.5, 31.5, 31.0, 
26.2, 26.1, 26.0; IR (Neat Film, NaCl) 2927, 2852, 1736, 1686, 1596, 1448, 1284, 1239, 1199, 
1154, 1128, 990, 928, 670 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C18H26NO3 [M+NH4]+: 
304.1907, found 304.1913. 
 
 
allyl 2-cyclohexyl-2-methyl-3-oxo-3-phenylpropanoate (SI6) 
To a flame-dried flask containing NaH (2 mmol, 80 mg, 60% dispersion in mineral oil) and DMF 
(6 mL) was added beta-ketoester SI5 (1 mmol, 286.4 mg) neat at 25 °C, and the resulting 
suspension stirred for 30 minutes.  MeI (2 mmol, 125 µL) was then added and the reaction 
continued at 25 °C for 1.5 h.  The reaction was quenched with saturated NH4Cl and diluted with 
water and Et2O.  The aqueous layer was extracted with Et2O and the combined organic layers 
dried over MgSO4.  The crude product was purified by silica gel flash chromatography (6% Et2O 
in hexanes) to afford the desired product as a colorless oil (240.6 mg, 80%) containing some of 
the undesired O-alkylated product: 1H NMR (500 MHz, CDCl3) δ 7.82–7.73 (m, 2H), 7.56–7.44 
(m, 1H), 7.43–7.34 (m, 2H), 5.68 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.22–5.08 (m, 2H), 4.60–4.49 
(m, 2H), 2.46 (tt, J = 11.9, 2.7 Hz, 1H), 1.87–1.64 (m, 5H), 1.64–1.49 (m, 1H), 1.46 (s, 3H), 
1.42–1.22 (m, 2H), 1.19–0.94 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 197.7, 173.3, 136.7, 
132.3, 131.3, 128.4, 128.3, 118.7, 65.6, 60.9, 42.6, 28.6, 28.0, 26.8, 26.8, 26.5, 17.7; IR (Neat 
Film, NaCl) 2930, 2853, 2360, 1734, 1684, 1447, 1258, 1233, 1186, 1153, 1121, 1081, 964, 700 
cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H25O3 [M+H]+: 301.1798, found 301.1787. 
 
 
 
O
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2-cyclohexyl-2-methyl-1-phenylpent-4-en-1-one (SI7) 
In a nitrogen-filled glovebox, a solution of Pd2(dba)3 (1.8 mg/mL) and L2 (2.8 mg/mL) in 
toluene was stirred for 30 minutes at 25 °C, then 0.5 mL of the resulting catalyst solution was 
added to a one dram vial containing beta-ketoester SI6 (0.2 mmol) dissolved in hexanes (1.5 
mL).  The vial was sealed with a Teflon-lined cap, removed from the glovebox, and stirred at 25 
°C for 12 h.  The crude reaction mixture was concentrated then purified by preparative TLC to 
provide the desired alkylation product as a colorless oil (27.0 mg, 53% yield); 37% ee, [α]D25 –
7.7 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.67–7.58 (m, 2H), 7.49–7.32 (m, 3H), 5.77–
5.53 (m, 1H), 5.13–4.87 (m, 2H), 2.72 (dd, J = 13.9, 6.6 Hz, 1H), 2.40–2.19 (m, 1H), 2.00 (tt, J = 
11.3, 2.9 Hz, 1H), 1.84–1.56 (m, 4H), 1.48 (dt, J = 9.1, 3.2 Hz, 1H), 1.35–1.03 (m, 8H); 13C 
NMR (100 MHz, CDCl3) δ 209.3, 140.3, 134.5, 130.8, 128.2, 127.6, 118.0, 55.3, 45.5, 42.2, 
28.8, 27.5, 27.1, 27.0, 26.7, 18.5; IR (Neat Film, NaCl) 2929, 2853, 1672, 1446, 1379, 1216, 
1002, 967, 916, 772, 723, 694 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C18H25O [M+H]+: 
257.1900, found 257.1894; SFC Conditions : 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 
210 nm, tR (min): major = 6.16, minor = 6.92. 
 
 
 
 
 
 
 
O
Me
O
O Pd2dba3 (0.5 mol %)
L2 (1.2 mol %)
hexane/toluene (3:1)
25 °C, 12 h
P N
O
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CF3
F3C
CF3
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Enantioselectivity Time Course Measurement 
 
In a nitrogen-filled glovebox, a solution of Pd2(dba)3 (1.8 mg/mL) and L2 (2.8 mg/mL) in 
toluene was stirred for 30 minutes at 25 °C, then 2.5 mL of the resulting catalyst solution was 
added to a vial containing 25:75 E/Z enol carbonate 1a (1.0 mmol) dissolved in hexanes (7.5 
mL).  The vial was sealed with a Teflon-lined cap, removed from the glovebox, and stirred at 25 
°C.  At the indicated time intervals, 250 µL of the reaction mixture was removed, filtered 
through a plug of silica, and purified by preparative TLC (10% Et2O in hexanes).  Analysis by 
chiral SFC showed that the ee of the product is initially high, and remains constant throughout 
the course of the reaction. 
Ph
OCO2allyl
Et
Ph
Pd2dba3 (0.5 mol %)
L2 (1.2 mol %)
3:1 hexane/PhMe
25 °C
Ph
O
Ph
Et
25:75 E/Z
time (min) eeentry
10 89.51
20 89.32
30 89.23
60 89.84
120 89.75
180 89.66
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